Emcure Pharmaceuticals IPO Details (Upcoming IPO)

Emcure Pharmaceuticals Ltd is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lies in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood- related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets & they are the domestic leader in three biologics. We are leading creation of India’s first indigenous mRNA vaccine to combat COVID- 19 which is currently under trials.

With 350+ brands, five R&D centers and 14 manufacturing facilities established across the country, we have ensured a strong foothold not just in India but also globally with a wide network across 70+ countries. Our state-of-the-art API facilities ensures that our supply chain is vertically integrated providing flexibility over control of manufacturing. We have cemented strategic global partnerships that are a result of alliances with local and multi-national companies which are at the helm of leadership in key therapeutic areas. The key objective of our widespread presence across markets is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

Emcure Pharmaceuticals IPO Details (Update Soon)
Issue Open	-
Issue Close	-
Allotment Date	-
Unblocked Amount	-
Credit Demat Amount	-
Listing Date	-
Issue Size	- Total Equity Share - Fresh Issue Equity Share - OFS Equity Share
Issue Size	₹ - Cr ₹ - Cr Fresh ₹ - Cr OFS
IPO Price Band	₹ -
Minimum Share Bid	-
Minimum Investment Amount [₹]	₹ -
Face Value	₹ -
Qualified Institutional Buyer [QIB]	- %
High Networth Individual [HNI]	- %
Retail Individual Investor [RII]	- %
Listing On	BSE & NSE

Emcure Pharmaceuticals IPO Rating
LiveIPO	-
Hem Security	-
-	-
-	-
-	-
-	-

Emcure Pharmaceuticals IPO Related Link
Emcure Pharmaceuticals IPO GMP Emcure Pharmaceuticals IPO Subscription Emcure Pharmaceuticals IPO Allotment Status

Emcure Pharmaceuticals IPO Financial Details (₹ in Cr)
Financial Year	Total Asset	Total Revenue	Total Expenses	Profit After Tax
FY-2019	5810.439	4815.590	4469.495	202.968
FY-2020	6004.055	5130.860	4922.046	100.610
FY-2021	6807.398	6091.806	5345.885	418.594
-	-	-	-	-

Emcure Pharmaceuticals IPO Valuation Details
Earnings Per Share [EPS]	₹ 21.68
Price/Earnings [P/E] Ratio	66.12
Return on Net Worth [RoNW]	17.25 %
Net Asset Value [NAV]	₹ 125.68 Per Share

Emcure Pharmaceuticals IPO Subscription Details
As on Date	QIB	NII	RII	Total
Shared Offered	-	-	-	-
Day-1 [-]	- [-]	- [-]	- [-]	- [-]
Day-2 [-]	- [-]	- [-]	- [-]	- [-]
Day-3 [-]	- [-]	- [-]	- [-]	- [-]

Emcure Pharmaceuticals IPO Grey Market Premium
Emcure Pharmaceuticals IPO Grey Market Premium :- Click Here

Emcure Pharmaceuticals IPO Allotment Status
Emcure Pharmaceuticals IPO Allotment Status :- Click Here

Emcure Pharmaceuticals IPO Live Subscription
Emcure Pharmaceuticals IPO Subscription in BSE:- Click Here to View Emcure Pharmaceuticals IPO Subscription in NSE:- Click Here to View

Emcure Pharmaceuticals IPO Prospectus
Emcure Pharmaceuticals IPO DRHP Emcure Pharmaceuticals IPO RHP (Update Soon)

Emcure Pharmaceuticals IPO Contact Details
Emcure Pharmaceuticals Ltd Plot No. P2, IT-BT Park, Phase II, M.I.D.C. Hinjawadi, Pune - 411057, Maharashtra, India. Tel: +(91) 20 35070033 Contact Person: B. Renganathan, Company Secretary and Compliance Officer; Tel: +(91) 20 66770000 / 4070 0000 E-mail: investors@emcure.co.in Website: www.emcure.com Corporate Identity Number: U24231PN1981PLC024251

Emcure Pharmaceuticals IPO Registrar
Link Intime India Private Limited C-101, 1st Floor, 247 Park L.B.S Marg, Vikhroli West Mumbai 400 083 Maharashtra, India Tel: +(91) 22 4918 6200 E-mail: emcurepharma.ipo@linkintime.co.in Investor grievance e-mail: emcurepharma.ipo@linkintime.co.in Website: www.linkintime.co.in Contact person: Shanti Gopalkrishnan SEBI registration number: INR000004058

Emcure Pharmaceuticals IPO Lead Managers

Axis Capital Limited 1st floor, Axis House C-2 Wadia International Centre P.B. Marg, Worli Mumbai 400 025, Maharashtra, India Tel: +91 22 4325 2183 E-mail: emcure.ipo@axiscap.in Website: www.axiscapital.co.in Investor Grievance ID: complaints@axiscap.in Contact Person: Simran Gadh SEBI Registration Number: INM000012029 BofA Securities India Limited Ground Floor, “A” Wing One BKC, “G” Block Bandra Kurla Complex Bandra (East), Mumbai 400 051 Maharashtra, India Tel: +(91) 22 6632 8000 E-mail: dg.ipo_emcure@bofa.com  Investor Grievance E-mail: dg.india_merchantbanking@bofa.com Contact Person: Stuti Bansal Website: www.ml-india.com SEBI Registration No.: INM000011625 Credit Suisse Securities (India) Private Limited 9th Floor, Ceejay House Plot F Shivsagar Estate, Dr. Annie Besant Road Worli Mumbai 400 018 Maharashtra, India Tel.: + (91) 22 6777 3885 E-mail: list.emcureipo@credit-suisse.com Investor Grievance E-mail: list.igcellmer-bnkg@credit-suisse.com Website: https://www.credit-suisse.com/in/en/investment-banking-apac/investment-banking-in-india/ipo.html Contact Person: Devesh Pandey SEBI Registration No.: INM000011161 JM Financial Limited 7th Floor, Cnergy, Appasaheb Marathe Marg Prabhadevi, Mumbai 400 025 Maharashtra, India Tel.: +91 22 6630 3030 E-mail: emcure.ipo@jmfl.com Investor grievance e-mail: grievance.ibd@jmfl.com Contact person: Prachee Dhuri Website: www.jmfl.com SEBI Registration: INM000010361 BOB Capital Markets Limited Parinee Crescenzo, 1704, B Wing, 17th Floor Plot no. C-38/39, G Block BKC Bandra East, Mumbai 400 051 Maharashtra, India Tel.: +(91) 22 6138 9300 E-mail: emcure.ipo@bobcaps.in Investor grievance e-mail: investorgrievance@bobcaps.in Website: www.bobcaps.in Contact person: Ninad Jape/Nivedika Chavan SEBI Registration No.: INM000009926

Emcure Pharmaceuticals IPO FAQs

What is Emcure Pharmaceuticals IPO? Emcure Pharmaceuticals IPO is a main-board IPO of - equity shares of the face value of ₹- aggregating up to ₹- Crores. The issue is priced at ₹- to ₹- per equity share. The minimum order quantity is - Shares. Link-Intime India Private Ltd is the registrar for this IPO. The Emcure Pharmaceuticals IPO are to be listed on BSE & NSE. When Emcure Pharmaceuticals IPO will Open and Close? The Emcure Pharmaceuticals IPO opens on - and closes on -. What is Emcure Pharmaceuticals IPO Price Band? Emcure Pharmaceuticals IPO Price Band is ₹- to ₹ - per equity share. What is the lot size of Emcure Pharmaceuticals IPO? Emcure Pharmaceuticals IPO the minimum bid is - Shares with ₹- amount and maximum bid is - shares with ₹-. When Emcure Pharmaceuticals IPO Allotment date? The Emcure Pharmaceuticals IPO Allotment will be done on -, and the allotted shares will be credited to your demat account on -. Check the Emcure Pharmaceuticals IPO Allotment status When is Emcure Pharmaceuticals IPO listing date? The Emcure Pharmaceuticals IPO listing date is on -. What is Emcure Pharmaceuticals IPO Expected Returns? Emcure Pharmaceuticals IPO Expected Returns is -% . How to Apply the Emcure Pharmaceuticals IPO? You can apply Emcure Pharmaceuticals IPO using ASBA online through your internet banking. You can also apply Emcure Pharmaceuticals IPO ASBA online via UPI ID through your stock brokers apps. You can also apply Emcure Pharmaceuticals IPO via your stock brokers’ office by filling up the offline application form and submit to your Bank.

Disclaimer:-

•       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO. •       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk •        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO. •       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.